These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 9443403

  • 1. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V, Jensen EV, Knabbe C.
    Cancer Res; 1998 Jan 15; 58(2):263-7. PubMed ID: 9443403
    [Abstract] [Full Text] [Related]

  • 2. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R.
    Cancer Res; 1997 Aug 15; 57(16):3486-93. PubMed ID: 9270017
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ.
    Breast Cancer Res; 2006 Aug 15; 8(1):R2. PubMed ID: 16417650
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F, Albaladejo V, Joly-Pharaboz MO, Nicolas B, Andre J.
    Endocrinology; 1992 Mar 15; 130(3):1145-52. PubMed ID: 1537281
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y, Ballejo G, Murphy LC, Murphy LJ.
    Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.
    Tong GM, Rajah TT, Zang XP, Pento JT.
    Anticancer Res; 2002 Apr 01; 22(1A):103-6. PubMed ID: 12017270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
    Poulin R, Merand Y, Poirier D, Levesque C, Dufour JM, Labrie F.
    Breast Cancer Res Treat; 1989 Oct 01; 14(1):65-76. PubMed ID: 2605344
    [Abstract] [Full Text] [Related]

  • 16. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME, Katzenellenbogen BS.
    J Steroid Biochem Mol Biol; 1996 Oct 01; 59(2):121-34. PubMed ID: 9010327
    [Abstract] [Full Text] [Related]

  • 17. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J, Jordan V.
    Endocrinology; 2001 Feb 01; 142(2):838-46. PubMed ID: 11159857
    [Abstract] [Full Text] [Related]

  • 18. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH, Parker CJ, Jordan VC.
    Cancer Res; 1992 Dec 01; 52(23):6539-46. PubMed ID: 1423300
    [Abstract] [Full Text] [Related]

  • 19. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J, Liu H, Bentrem DJ, Zapf JW, Jordan VC.
    Cancer Res; 2000 Sep 15; 60(18):5097-105. PubMed ID: 11016635
    [Abstract] [Full Text] [Related]

  • 20. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 15; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.